Home › Compare › ABEPF vs JNJ

ABEPF vs JNJ: Dividend Comparison 2026

ABEPF yields 18264.84% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ABEPF wins by $21325239325997563904.00M in total portfolio value
10 years
ABEPF
ABEPF
● Live price
18264.84%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21325239325997563904.00M
Annual income
$21,098,010,510,433,460,000,000,000.00
Full ABEPF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ABEPF vs JNJ

📍 ABEPF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodABEPFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ABEPF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ABEPF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ABEPF
Annual income on $10K today (after 15% tax)
$1,552,511.42/yr
After 10yr DRIP, annual income (after tax)
$17,933,308,933,868,440,000,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, ABEPF beats the other by $17,933,308,933,868,440,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ABEPF + JNJ for your $10,000?

ABEPF: 50%JNJ: 50%
100% JNJ50/50100% ABEPF
Portfolio after 10yr
$10662619662998781952.00M
Annual income
$10,549,005,255,216,730,000,000,000.00/yr
Blended yield
98.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ABEPF
No analyst data
Altman Z
-3.9
Piotroski
1/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ABEPF buys
0
JNJ buys
0
No recent congressional trades found for ABEPF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricABEPFJNJ
Forward yield18264.84% ✓3.36%
Annual dividend / share$2.00$4.96 ✓
Payout ratio50% ✓55%
1-year div growth0%4.2% ✓
5-year div CAGR0%5.8% ✓
Portfolio after 10y$21325239325997563904.00M ✓$20.0K
Annual income after 10y$21,098,010,510,433,460,000,000,000.00 ✓$827.78
Total dividends collected$21310234227088474112.00M ✓$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ABEPF vs JNJ ($10,000, DRIP)

YearABEPF PortfolioABEPF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$1,837,184$1,826,484.02$10,676$355.77+$1.83M → ABEPF
2$315,572,072$313,606,284.86$11,407$389.39+$315.56M → ABEPF
3$50,681,565,137$50,343,903,019.87$12,198$426.53+$50681.55M → ABEPF
4$7,610,622,702,742$7,556,393,428,045.77$13,056$467.62+$7610622.69M → ABEPF
5$1,068,619,644,031,122$1,060,476,277,739,187.50$13,987$513.12+$1068619644.02M → ABEPF
6$140,305,256,319,377,580$139,161,833,300,264,260.00$14,998$563.56+$140305256319.36M → ABEPF
7$17,226,166,169,284,534,000$17,076,039,545,022,800,000.00$16,098$619.52+$17226166169284.52M → ABEPF
8$1,977,809,264,574,288,000,000$1,959,377,266,773,153,300,000.00$17,295$681.69+$1977809264574288.00M → ABEPF
9$212,363,379,031,874,070,000,000$210,247,123,118,779,570,000,000.00$18,599$750.82+$212363379031874080.00M → ABEPF
10$21,325,239,325,997,565,000,000,000$21,098,010,510,433,460,000,000,000.00$20,022$827.78+$21325239325997563904.00M → ABEPF

ABEPF vs JNJ: Complete Analysis 2026

ABEPF — Stock

Vision Lithium Inc., a mineral exploration company, engages in the exploration and evaluation of mineral resources in Québec, Canada. The company explores for lithium, gold, copper, zinc, and base metals. Its flagship project is the Godslith lithium property covering an area of 5,560 hectares located to the northwest of Gods River, Manitoba. The company was formerly known as ABE Resources Inc. and changed its name to Vision Lithium Inc. in March 2018. Vision Lithium Inc. was incorporated in 1997 and is headquartered in Val-d'Or, Canada.

Full ABEPF Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ABEPF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ABEPF vs SCHDABEPF vs JEPIABEPF vs OABEPF vs KOABEPF vs MAINABEPF vs ABBVABEPF vs MRKABEPF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.